Hepatitis B DNA vaccine - Merck & Co
Alternative Names: HBV DNA vaccine - MerckLatest Information Update: 25 Sep 2023
At a glance
- Originator Merck & Co
- Developer Fresh Tracks Therapeutics
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B